title

ASCO eLearning Podcasts

ASCO eLearning

4
Followers
5
Plays
ASCO eLearning Podcasts

ASCO eLearning Podcasts

ASCO eLearning

4
Followers
5
Plays
OVERVIEWEPISODESYOU MAY ALSO LIKE

Details

About Us

The ASCO eLearning Podcast is an educational series focused on helping learners identify knowledge gaps and stay up-to-date with the latest in new drug developments, cancer treatments and patient care approaches.The purpose of this podcast is to educate and to inform. This podcast is provided on the understanding that it does not constitute medical or other professional advice or services. It is no substitute for professional care by a doctor or other qualified medical professional and is not intended for use in the diagnosis or treatment of individual conditions. Guests who speak in this podcast express their own opinions, experience and conclusions. Neither American Society of Clinical Oncology nor any of its affiliates endorses, supports or opposes any particular treatment option or other matter discussed in this podcast. The mention of any product, service, organization, activity or therapy on the Podcast should not be construed as an ASCO endorsement.

Latest Episodes

ASCO Guidelines: Molecular Biomarkers in Localized Prostate Cancer Guideline

An interview with Dr. Scott Eggener of University of Chicago Medicine on "Molecular Biomarkers in Localized Prostate Cancer: ASCO Guideline." This guideline provides recommendations for available tissue-based prostate cancer biomarkers geared toward patient selection for active surveillance, identification of clinically significant disease, choice of postprostatectomy adjuvant versus salvage radiotherapy, and to address emerging questions such as the relative value of tissue biomarkers compared with MRI. Read the full guideline atwww.asco.org/genitourinary-cancer-guidelines

9 MIN2019 DEC 18
Comments
ASCO Guidelines: Molecular Biomarkers in Localized Prostate Cancer Guideline

ASCO Guidelines: Patient-Centered Standards for Medically Integrated Dispensing: ASCO/NCODA Standards

An interview with Dr. Melissa Dillmon on the Patient-Centered Standards for Medically Integrated Dispensing: ASCO/NCODA Standards. The interview covers the findings of the systematic review, which were consistent with the NCODA patient-centered standards for patient relationships and education, adherence, safety, collection of data, documentation and other areas. NCODA standards were adopted and used as basis for these ASCO/NCODA standards. Additional information is available at www.asco.org/mid-standards.

6 MIN2019 DEC 11
Comments
ASCO Guidelines: Patient-Centered Standards for Medically Integrated Dispensing: ASCO/NCODA Standards

Management of Immune-related Adverse Events Refractory to Standard Therapies

Dr. Doug Johnson, clinical director of the melanoma program and assistant professor of medicine at Vanderbilt University Medical Center, discusses the management of immune-related adverse events refractory to standard therapies. If you enjoyed this podcast, make sure to subscribe for more weekly education content from ASCO University. We truly value your feedback and suggestions, so please take a minute to leave a review. If you are an oncology professional and interested in contributing to the ASCO University Weekly Podcast, emailascou@asco.orgfor more information. TRANSCRIPT [INTRO MUSIC PLAYING] Welcome to the ASCO University Weekly Podcast. My name is Doug Johnson. I'm the clinical director of the melanoma program, assistant professor of medicine at Vanderbilt University Medical Center. Today we'll discuss management of immune-related adverse events refractory to standard therapies. As a background to today's discussion, immune checkpoint inhibitor are active therapies and FDA a...

5 MIN2019 DEC 4
Comments
Management of Immune-related Adverse Events Refractory to Standard Therapies

ASCO Guidelines: Disease Management for Patients With Advanced HER2 Positive Breast Cancer and Brain Metastases Guideline

An interview with Dr. Naren Ramakrishna fromUniversity of Florida Health Cancer Center at Orlando Health on the guideline update which addressesmanagement of brain metastases for patients with human epidermal growth factor receptor 2–positive advanced breast cancer. Read the full guideline atwww.asco.org/breast-cancer-guidelines

7 MIN2019 NOV 20
Comments
ASCO Guidelines: Disease Management for Patients With Advanced HER2 Positive Breast Cancer and Brain Metastases Guideline

ASCO Guidelines: Management of the Neck in Squamous Cell Carcinoma of the Oral Cavity and Oropharynx Guideline

The purpose of this podcast is to educate and to inform. This is not a substitute for professional medical care and is not intended for use in the diagnosis or treatment of individual conditions. Guests on this podcast express their own opinions, experience, and conclusions. The mention of any product, service, organization, activity, or therapy should not be construed as an ASCO endorsement. Hello and welcome to the ASCO Guidelines podcast series. My name is Shannon McKernin, and today I'm interviewing Dr. Shlomo Koyfman from the Cleveland Clinic, lead author on "Management of the Neck in Squamous Cell Carcinoma of the Oral Cavity and Oropharynx: ASCO Clinical Practice Guideline." Thank you for being here today, Dr. Koyfman. It's a pleasure. So first, can you give us a general overview of what this guideline covers? Yeah, so this is an exciting guideline because it covers a topic that we don't usually think about in head and neck cancer in a formal way, and that is management of th...

13 MIN2019 NOV 13
Comments
ASCO Guidelines: Management of the Neck in Squamous Cell Carcinoma of the Oral Cavity and Oropharynx Guideline

ASCO Guidelines: Antimicrobial Prophylaxis for Adult Patients with Cancer-Related Immunosuppression Guideline

The purpose of this podcast is to educate and to inform. This is not a substitute for professional medical care and is not intended for use in the diagnosis or treatment of individual conditions. Guests on this podcast express their own opinions, experience, and conclusions. The mention of any product, service, organization, activity, or therapy should not be construed as an ASCO endorsement. Hello and welcome to the ASCO Guidelines podcast series. My name is Shannon McKernin, and today I'm interviewing Dr. Randy Taplitz from UC San Diego Health, lead author on Antimicrobial Prophylaxis for Adult Patients With Cancer-Related Immunosuppression: ASCO and IDSA Clinical Practice Guideline Update. Thank you for being here, Dr. Taplitz. Thank you. So first, can you give us a general overview of what this guideline covers? Yes. I mean, I think we're all aware that infection in the setting of neutropenia associated with cancer chemotherapy is really a major cause of morbidity in these patie...

10 MIN2019 NOV 6
Comments
ASCO Guidelines: Antimicrobial Prophylaxis for Adult Patients with Cancer-Related Immunosuppression Guideline

ASCO Guidelines: Treatment of Patients with Early-Stage Colorectal Cancer Resource-Stratified Guideline

The purpose of this podcast is to educate and to inform. This is not a substitute for professional medical care and is not intended for use in the diagnosis or treatment of individual conditions. Guests on this podcast express their own opinions, experience, and conclusions. The mention of any product, service, organization, activity, or therapy should not be construed as an ASCO endorsement. Hello, and welcome to the ASCO Guidelines Podcast series. My name is Shannon McKernin. And today, I'm interviewing Dr. Manish Shah from New York Presbyterian Weill Cornell Medical Center, senior author on "Treatment of Patients with Early-Stage Colorectal Cancer: ASCO Resource-Stratified Guideline." Thank you for being here today, Dr. Shah. Thank you, it's a pleasure and honor to be here. So first, can you give us a general overview of what this guideline covers? Yes, absolutely. So the "Treatment of Patients with Early-Stage Colorectal Cancer" is a resource-stratified guideline. And it focuses...

11 MIN2019 OCT 30
Comments
ASCO Guidelines: Treatment of Patients with Early-Stage Colorectal Cancer Resource-Stratified Guideline

ASCO Guidelines: Role of Patient and Disease Factors in Adjuvant Systemic Therapy Decision-Making for Early-Stage, Operable Breast Cancer Update

An interview with Dr. Lynn Henry fromUniversity of Utah Huntsman Cancer Institute on "Role of Patient and Disease Factors in Adjuvant Systemic Therapy Decision-Making for Early-Stage, Operable Breast Cancer: Update of the ASCO Endorsement of CCO Guideline." This guideline update includes data from the MINDACT and TAILORx trials to clarify the recommendations forpatients with hormone receptor-positive, HER2 not overexpressed, axillary node-negative early breast cancer. Read the full guideline atwww.asco.org/breast-cancer-guidelines TRANSCRIPT The purpose of this podcast is to educate and to inform. This is not a substitute for professional medical care and is not intended for use in the diagnosis or treatment of individual conditions. Guests on this podcast express their own opinions, experience, and conclusions. The mention of any product, service, organization, activity, or therapy should not be construed as an ASCO endorsement. Hello and welcome to the ASCO Guidelines Podcast Seri...

10 MIN2019 OCT 23
Comments
ASCO Guidelines: Role of Patient and Disease Factors in Adjuvant Systemic Therapy Decision-Making for Early-Stage, Operable Breast Cancer Update

ASCO Voices 2019: I Promised

I Promisedpresented by Ashley Sumrall, MD, FACPat ASCO Annual Meeting 2019

8 MIN2019 OCT 16
Comments
ASCO Voices 2019: I Promised

ASCO Guidelines: Medication-Related Osteonecrosis of the Jaw Guideline

An interview with Dr. Noam Yarom, Dr. Charles Shapiro, Dr. Deborah Saunders and Dr. Doug Peterson on "Medication-Related Osteonecrosis of the Jaw: MASCC/ISOO/ASCO Clinical Practice Guideline." This guideline addresses the prevention and management of MRONJ in patients with cancer. This guideline is intended for oncologists and other physicians, dentists, dental specialists, oncology nurses, clinical researchers, oncology pharmacists, advanced practitioners, and patients with cancer. Read the full guideline atwww.asco.org/supportive-care-guidelines Find all of the ASCO podcasts at podcast.asco.org TRANSCRIPT Disclaimer: The purpose of this podcast is to educate and to inform. This is not a substitute for professional medical care and is not intended for use in the diagnosis or treatment of individual conditions. Guests on this podcast express their own opinions, experience, and conclusions. The mention of any product, service, organization, activity, or therapy should not be construe...

18 MIN2019 OCT 9
Comments
ASCO Guidelines: Medication-Related Osteonecrosis of the Jaw Guideline

Latest Episodes

ASCO Guidelines: Molecular Biomarkers in Localized Prostate Cancer Guideline

An interview with Dr. Scott Eggener of University of Chicago Medicine on "Molecular Biomarkers in Localized Prostate Cancer: ASCO Guideline." This guideline provides recommendations for available tissue-based prostate cancer biomarkers geared toward patient selection for active surveillance, identification of clinically significant disease, choice of postprostatectomy adjuvant versus salvage radiotherapy, and to address emerging questions such as the relative value of tissue biomarkers compared with MRI. Read the full guideline atwww.asco.org/genitourinary-cancer-guidelines

9 MIN2019 DEC 18
Comments
ASCO Guidelines: Molecular Biomarkers in Localized Prostate Cancer Guideline

ASCO Guidelines: Patient-Centered Standards for Medically Integrated Dispensing: ASCO/NCODA Standards

An interview with Dr. Melissa Dillmon on the Patient-Centered Standards for Medically Integrated Dispensing: ASCO/NCODA Standards. The interview covers the findings of the systematic review, which were consistent with the NCODA patient-centered standards for patient relationships and education, adherence, safety, collection of data, documentation and other areas. NCODA standards were adopted and used as basis for these ASCO/NCODA standards. Additional information is available at www.asco.org/mid-standards.

6 MIN2019 DEC 11
Comments
ASCO Guidelines: Patient-Centered Standards for Medically Integrated Dispensing: ASCO/NCODA Standards

Management of Immune-related Adverse Events Refractory to Standard Therapies

Dr. Doug Johnson, clinical director of the melanoma program and assistant professor of medicine at Vanderbilt University Medical Center, discusses the management of immune-related adverse events refractory to standard therapies. If you enjoyed this podcast, make sure to subscribe for more weekly education content from ASCO University. We truly value your feedback and suggestions, so please take a minute to leave a review. If you are an oncology professional and interested in contributing to the ASCO University Weekly Podcast, emailascou@asco.orgfor more information. TRANSCRIPT [INTRO MUSIC PLAYING] Welcome to the ASCO University Weekly Podcast. My name is Doug Johnson. I'm the clinical director of the melanoma program, assistant professor of medicine at Vanderbilt University Medical Center. Today we'll discuss management of immune-related adverse events refractory to standard therapies. As a background to today's discussion, immune checkpoint inhibitor are active therapies and FDA a...

5 MIN2019 DEC 4
Comments
Management of Immune-related Adverse Events Refractory to Standard Therapies

ASCO Guidelines: Disease Management for Patients With Advanced HER2 Positive Breast Cancer and Brain Metastases Guideline

An interview with Dr. Naren Ramakrishna fromUniversity of Florida Health Cancer Center at Orlando Health on the guideline update which addressesmanagement of brain metastases for patients with human epidermal growth factor receptor 2–positive advanced breast cancer. Read the full guideline atwww.asco.org/breast-cancer-guidelines

7 MIN2019 NOV 20
Comments
ASCO Guidelines: Disease Management for Patients With Advanced HER2 Positive Breast Cancer and Brain Metastases Guideline

ASCO Guidelines: Management of the Neck in Squamous Cell Carcinoma of the Oral Cavity and Oropharynx Guideline

The purpose of this podcast is to educate and to inform. This is not a substitute for professional medical care and is not intended for use in the diagnosis or treatment of individual conditions. Guests on this podcast express their own opinions, experience, and conclusions. The mention of any product, service, organization, activity, or therapy should not be construed as an ASCO endorsement. Hello and welcome to the ASCO Guidelines podcast series. My name is Shannon McKernin, and today I'm interviewing Dr. Shlomo Koyfman from the Cleveland Clinic, lead author on "Management of the Neck in Squamous Cell Carcinoma of the Oral Cavity and Oropharynx: ASCO Clinical Practice Guideline." Thank you for being here today, Dr. Koyfman. It's a pleasure. So first, can you give us a general overview of what this guideline covers? Yeah, so this is an exciting guideline because it covers a topic that we don't usually think about in head and neck cancer in a formal way, and that is management of th...

13 MIN2019 NOV 13
Comments
ASCO Guidelines: Management of the Neck in Squamous Cell Carcinoma of the Oral Cavity and Oropharynx Guideline

ASCO Guidelines: Antimicrobial Prophylaxis for Adult Patients with Cancer-Related Immunosuppression Guideline

The purpose of this podcast is to educate and to inform. This is not a substitute for professional medical care and is not intended for use in the diagnosis or treatment of individual conditions. Guests on this podcast express their own opinions, experience, and conclusions. The mention of any product, service, organization, activity, or therapy should not be construed as an ASCO endorsement. Hello and welcome to the ASCO Guidelines podcast series. My name is Shannon McKernin, and today I'm interviewing Dr. Randy Taplitz from UC San Diego Health, lead author on Antimicrobial Prophylaxis for Adult Patients With Cancer-Related Immunosuppression: ASCO and IDSA Clinical Practice Guideline Update. Thank you for being here, Dr. Taplitz. Thank you. So first, can you give us a general overview of what this guideline covers? Yes. I mean, I think we're all aware that infection in the setting of neutropenia associated with cancer chemotherapy is really a major cause of morbidity in these patie...

10 MIN2019 NOV 6
Comments
ASCO Guidelines: Antimicrobial Prophylaxis for Adult Patients with Cancer-Related Immunosuppression Guideline

ASCO Guidelines: Treatment of Patients with Early-Stage Colorectal Cancer Resource-Stratified Guideline

The purpose of this podcast is to educate and to inform. This is not a substitute for professional medical care and is not intended for use in the diagnosis or treatment of individual conditions. Guests on this podcast express their own opinions, experience, and conclusions. The mention of any product, service, organization, activity, or therapy should not be construed as an ASCO endorsement. Hello, and welcome to the ASCO Guidelines Podcast series. My name is Shannon McKernin. And today, I'm interviewing Dr. Manish Shah from New York Presbyterian Weill Cornell Medical Center, senior author on "Treatment of Patients with Early-Stage Colorectal Cancer: ASCO Resource-Stratified Guideline." Thank you for being here today, Dr. Shah. Thank you, it's a pleasure and honor to be here. So first, can you give us a general overview of what this guideline covers? Yes, absolutely. So the "Treatment of Patients with Early-Stage Colorectal Cancer" is a resource-stratified guideline. And it focuses...

11 MIN2019 OCT 30
Comments
ASCO Guidelines: Treatment of Patients with Early-Stage Colorectal Cancer Resource-Stratified Guideline

ASCO Guidelines: Role of Patient and Disease Factors in Adjuvant Systemic Therapy Decision-Making for Early-Stage, Operable Breast Cancer Update

An interview with Dr. Lynn Henry fromUniversity of Utah Huntsman Cancer Institute on "Role of Patient and Disease Factors in Adjuvant Systemic Therapy Decision-Making for Early-Stage, Operable Breast Cancer: Update of the ASCO Endorsement of CCO Guideline." This guideline update includes data from the MINDACT and TAILORx trials to clarify the recommendations forpatients with hormone receptor-positive, HER2 not overexpressed, axillary node-negative early breast cancer. Read the full guideline atwww.asco.org/breast-cancer-guidelines TRANSCRIPT The purpose of this podcast is to educate and to inform. This is not a substitute for professional medical care and is not intended for use in the diagnosis or treatment of individual conditions. Guests on this podcast express their own opinions, experience, and conclusions. The mention of any product, service, organization, activity, or therapy should not be construed as an ASCO endorsement. Hello and welcome to the ASCO Guidelines Podcast Seri...

10 MIN2019 OCT 23
Comments
ASCO Guidelines: Role of Patient and Disease Factors in Adjuvant Systemic Therapy Decision-Making for Early-Stage, Operable Breast Cancer Update

ASCO Voices 2019: I Promised

I Promisedpresented by Ashley Sumrall, MD, FACPat ASCO Annual Meeting 2019

8 MIN2019 OCT 16
Comments
ASCO Voices 2019: I Promised

ASCO Guidelines: Medication-Related Osteonecrosis of the Jaw Guideline

An interview with Dr. Noam Yarom, Dr. Charles Shapiro, Dr. Deborah Saunders and Dr. Doug Peterson on "Medication-Related Osteonecrosis of the Jaw: MASCC/ISOO/ASCO Clinical Practice Guideline." This guideline addresses the prevention and management of MRONJ in patients with cancer. This guideline is intended for oncologists and other physicians, dentists, dental specialists, oncology nurses, clinical researchers, oncology pharmacists, advanced practitioners, and patients with cancer. Read the full guideline atwww.asco.org/supportive-care-guidelines Find all of the ASCO podcasts at podcast.asco.org TRANSCRIPT Disclaimer: The purpose of this podcast is to educate and to inform. This is not a substitute for professional medical care and is not intended for use in the diagnosis or treatment of individual conditions. Guests on this podcast express their own opinions, experience, and conclusions. The mention of any product, service, organization, activity, or therapy should not be construe...

18 MIN2019 OCT 9
Comments
ASCO Guidelines: Medication-Related Osteonecrosis of the Jaw Guideline
hmly
himalayaプレミアムへようこそ聴き放題のオーディオブックをお楽しみください。